8-Oxoadenosine>98.0%(HPLC)1g

(Hexahydroindolizin-8a(1H)-yl)methanol, 97%, 250mg

2-(4-(Trifluoromethyl)phenyl)pyridine, 98.0%, 5g

GC capillary column ROTI®Cap-5, 25 m, 0.32 mm, 1.00 µm, 1 Piece(s)

2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate, 98.0%, 1g

amino(5-bromo-2-methoxyphenyl)acetic acid, 95.0%, 250mg

1,1-Bis(trifluoromethyl)-cyclopentane, 95.0%, 1g

3-(3-ethylphenoxy)azetidine hydrochloride, 95.0%, 250mg

Tert-butyl 4-(1H-pyrrolo[2,3-b]pyridin-2-yl)piperidine-1-carboxylate, 98%, 5g

3,4-Dibromo-7-azaindole, 95.0%, 1g

Volumetric flasks class A opaque, 500 ml, 19/26, 2 Piece(s)

2-amino-1-cyclopropyl-1-(2-thienyl)ethanol, 95.0%, 250mg

5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one, 95.0%, 50mg